OpenAlex
PricingAboutJobs
Log inGet started
Work

Semaglutide for the Treatment of Obesity in Children 6 to <12 Years of Age

HTML

Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
DOI: 10.1056/nejmoa2604058
Authors: Ania M. Jastreboff, Nina M. Harder-Lauridsen, Michelle Van Name, Antje Körner, Aaron S. Kelly, Daniel Weghuber, Jens-Christian Holm, Christine Frithioff-Bøjsøe, Shilpa Middolu, Tina Buch, Martin Wabitsch
Institutions: Yale University, Novo Nordisk (Denmark), Helmholtz Munich, University Hospital Leipzig, Leipzig University, University of Minnesota, Paracelsus Medical University, University of Copenhagen, Holbæk Sygehus, Novo Nordisk Foundation Center for Basic Metabolic Research, Novo Nordisk (India), Universität Ulm, University Hospital Ulm
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: semaglutide, childhood obesity, GLP-1 receptor agonists, body mass index reduction, weight loss, lifestyle modification, adverse events, gastrointestinal adverse effects, drug safety in children, adolescents, adults, washout period
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk
OpenAlex ID: W7234565486
FWCI:
Cites: 23
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security